Abstract
To evaluate the effectiveness of a selective serotonin and norepinephrine reuptake inhibitor (SSNRI), Venlafaxine was used to alleviate problem urine marking in castrated male cats. Randomized placebo-controlled trial double-blind clinical trial. Twenty castrated male cats more than one-year-old objectionable reduction urine marking behavior. Owners recorded urine marking happening for two weeks. Cats that vertically marked a mean of ≥6 times per week were treated for two weeks by Venlafaxine or sterile water as placebo. Associated by decreasing the urine marking behavior if the urine marking decreased by 70 percent the treatment continued for 4 weeks and receiving was continued. The comparison of two groups showed that the second group that took drug had stronger significant correlation (P=0.001) despite the placebo controlled trial (P=0.021).

This publication has 16 references indexed in Scilit: